TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)

October 25, 2024 7:46 AM

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $175.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found